Healthcare provider profile · identity verified

Anthony P Kusek, MD

Allopathic & Osteopathic Physicians|Family Medicine · ALBION, NE · NPI 1760417901

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Anthony P Kusek, MD received $17.08 in general payments during 2025 across 1 reported records.

ABBVIE INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$17.08

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$17.08	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$17.08	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
DALVANCE Normalized: dalvance	Drug	ABBVIE INC.	$17.08	1	2025
Source payment records 2025-09-09 · ABBVIE INC. · $17.08 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$17.08	1	2025
Source payment records 2025-09-09 · ABBVIE INC. · $17.08 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	790	121
Levothyroxine Sodium	Levothyroxine Sodium	568	81
Rosuvastatin Calcium	Rosuvastatin Calcium	515	85
Omeprazole	Omeprazole	445	68
Metoprolol Succinate	Metoprolol Succinate	405	57
Amlodipine Besylate	Amlodipine Besylate	396	70
Tamsulosin Hcl	Tamsulosin Hcl	310	52
Metformin Hcl	Metformin Hcl	297	47
Lisinopril	Lisinopril	275	43
Valsartan	Valsartan	252	40
Potassium Chloride	Potassium Chloride	250	34
Pantoprazole Sodium	Pantoprazole Sodium	238	35
Furosemide	Furosemide	225	36
Gabapentin	Gabapentin	219	34
Losartan Potassium	Losartan Potassium	202	30
Donepezil Hcl	Donepezil Hcl	195	24
Fluticasone Propionate	Fluticasone Propionate	194	49
Allopurinol	Allopurinol	185	31
Sertraline Hcl	Sertraline Hcl	160	22
Famotidine	Famotidine	158	29
Hydrochlorothiazide	Hydrochlorothiazide	156	33
Carvedilol	Carvedilol	153	22
Metoprolol Tartrate	Metoprolol Tartrate	146	21
Warfarin Sodium	Warfarin Sodium	138	22
Trazodone Hcl	Trazodone Hcl	136	20
Simvastatin	Simvastatin	133	23
Glimepiride	Glimepiride	125	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	125	23
Eliquis	Apixaban	123	17
Ezetimibe	Ezetimibe	123	16
Prednisone	Prednisone	122	60
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	121	22
Clopidogrel	Clopidogrel Bisulfate	117	17
Xarelto	Rivaroxaban	117	18
Finasteride	Finasteride	108	14
Shingrix	Varicella-Zoster Ge/As01b/Pf	108	80
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	99	17
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	92	92
Duloxetine Hcl	Duloxetine Hcl	91	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	14
Meloxicam	Meloxicam	80	19
Pravastatin Sodium	Pravastatin Sodium	77	15
Mirtazapine	Mirtazapine	72	suppressed
Tramadol Hcl	Tramadol Hcl	72	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	13
Venlafaxine Hcl Er	Venlafaxine Hcl	62	suppressed
Celecoxib	Celecoxib	61	12
Ozempic	Semaglutide	61	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	59	48
Ropinirole Hcl	Ropinirole Hcl	57	suppressed
Buspirone Hcl	Buspirone Hcl	53	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Benazepril Hcl	Benazepril Hcl	49	suppressed
Propranolol Hcl	Propranolol Hcl	48	suppressed
Spironolactone	Spironolactone	47	suppressed
Cholestyramine	Cholestyramine (With Sugar)	44	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	43	suppressed
Novolog Flexpen	Insulin Aspart	43	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Atenolol	Atenolol	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Azithromycin	Azithromycin	38	25
Alendronate Sodium	Alendronate Sodium	37	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	37	37
Meclizine Hcl	Meclizine Hcl	37	15
Memantine Hcl	Memantine Hcl	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	35	suppressed
Bumetanide	Bumetanide	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	16
Albuterol Sulfate Hfa	Albuterol Sulfate	24	12
Misoprostol	Misoprostol	24	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Modafinil	Modafinil	22	suppressed
Ranolazine Er	Ranolazine	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	20	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	20	suppressed
Metolazone	Metolazone	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Digoxin	Digoxin	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Naproxen	Naproxen	14	suppressed
Sulfasalazine	Sulfasalazine	14	suppressed
Torsemide	Torsemide	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Dofetilide	Dofetilide	13	suppressed
Entacapone	Entacapone	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Ondansetron Odt	Ondansetron	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Baclofen	Baclofen	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$17.08 · 1 records	ABBVIE INC.	DALVANCE, UBRELVY	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error